Abstract:
Juvenile idiopathic arthritis (JIA) is a destructive and inflammatory joint disease with unknown etiology, complex immunoaggressive pathogenesis, characterized
by symmetrical chronic arthritis, systemic damage to internal organs, leading to disability in sick children [1]. In this regard, the problem of increasing the effectiveness of therapy for this disease is extremely relevant, both from the point of view of scientific and practical pediatrics.
